The Latest Breaking News from Autism

Nearly half of Britain's young people not in education, employment or training (NEET) are now classified as disabled, with mental health and autism driving a sharp rise in long-term worklessness.

Kimberly-Clark to acquire Kenvue, owner of Tylenol, in a £40 billion deal amid controversy over the painkiller's safety concerns and declining sales.

Every week of 2025 seems to bring a new health headline, whether it’s about climbing autism rates, changing vaccination recommendations or unexpected cancer risks.

Paul Scholes reveals why he stepped back from punditry to care for his autistic son, Aiden, offering a heartfelt glimpse into family life beyond football.

I can say from personal experience that being diagnosed with autism spectrum disorder can feel very isolating. Increasingly, however, it’s not unusual.

Texas sues Tylenol's makers over autism risks, echoing Trump-era legal battles over health misinformation with potential billions at stake.

Lawsuit comes after Trump’s baseless claims that acetaminophen can cause autism and ADHD in children

Texas Attorney General Ken Paxton has filed a lawsuit against Johnson Johnson (NYSE:JNJ) and Kenvue Inc (NYSE:KVUE), accusing the companies of misleading pregnant women about the safety of Tylenol despite evidence suggesting its active ingredient, acetaminophen, may increase the risk of autism and attention disorders in children.

Texas Attorney General Ken Paxton is accusing the companies behind Tylenol of deceptively marketing the pain reliever to pregnant mothers